NCT00042978: Carboplatin and Etoposide With or Without Oblimersen Sodium in Treating Patients With Extensive Stage Small Cell Lung Cancer |
|
|
| Completed | 2 | 55 | US | oblimersen sodium, augmerosen, G3139, G3139 bcl-2 antisense oligodeoxynucleotide, Genasense, carboplatin, Carboplat, CBDCA, JM-8, Paraplat, Paraplatin, etoposide, EPEG, VP-16, VP-16-213 | National Cancer Institute (NCI) | Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer | 05/05 | | | |
NCT00005032: Bcl-2 Antisense Oligodeoxynucleotide G3139 and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer |
|
|
| Completed | 1/2 | 12 | US | oblimersen sodium, paclitaxel | University of Chicago, National Cancer Institute (NCI) | Lung Cancer | 01/01 | 09/01 | | |
NCT00003103: Chemotherapy in Treating Patients With Solid Tumors |
|
|
| Completed | 1/2 | 57 | US | oblimersen sodium, docetaxel | Memorial Sloan Kettering Cancer Center | Bladder Cancer, Breast Cancer, Colorectal Cancer, Esophageal Cancer, Head and Neck Cancer, Kidney Cancer, Lung Cancer, Ovarian Cancer, Prostate Cancer, Unspecified Adult Solid Tumor, Protocol Specific | 08/02 | 08/02 | | |
